Estimated Annual Spending on Lecanemab and Its Ancillary Costs in the US Medicare Program

被引：20

作者：

Arbanas, Julia Cave ^{[1
]}

Damberg, Cheryl L. ^{[2
]}

Leng, Mei ^{[1
]}

Harawa, Nina ^{[1
,3
]}

Sarkisian, Catherine A. ^{[1
,4
]}

Landon, Bruce E. ^{[5
,6
]}

Mafi, John N. ^{[1
,2
,7
]}

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA USA

[2] RAND Corp, Santa Monica, CA USA

[3] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA USA

[4] VA Greater Los Angeles Healthcare Syst, Geriatr Res & Clin Ctr GRECC, Los Angeles, CA USA

[5] Harvard Med Sch, Boston, MA USA

[6] Beth Israel Deaconess Med Ctr, Div Gen Med, Boston, MA USA

[7] UCLA, David Geffen Sch Med, Div Gen Med & Hlth Serv Res, Dept Med, 1100 Glendon Ave,908, Los Angeles, CA 90024 USA

来源：

JAMA INTERNAL MEDICINE | 2023年 / 183卷 / 08期

关键词：

D O I：

10.1001/jamainternmed.2023.1749

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This cross-sectional cost analysis uses data from the 2018 Health and Retirement Study to estimate the potential future Medicare spending and beneficiary costs for lecanemab.

引用

页码：885 / 889

页数：5

共 6 条

[1] Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study
Doraiswamy, P. M.
Sperling, R. A.
Johnson, K.
Reiman, E. M.
Wong, T. Z.
Sabbagh, M. N.
Sadowsky, C. H.
Fleisher, A. S.
Carpenter, A.
Joshi, A. D.
Lu, M.
Grundman, M.
Mintun, M. A.
Skovronsky, D. M.
Pontecorvo, M. J.
[J]. MOLECULAR PSYCHIATRY, 2014, 19 (09) : 1044 - 1051
[2] Cognitive Assessment At Medicare's Annual Wellness Visit In Fee-For-Service And Medicare Advantage Plans
Jacobson, Mireille
Thunell, Johanna
Zissimopoulos, Julie
[J]. HEALTH AFFAIRS, 2020, 39 (11) : 1935 - 1942
[3] National estimates of the quantity and cost of informal caregiving for the elderly with dementia
Langa, KM
Chernew, ME
Kabeto, MU
Herzog, AR
Ofstedal, MB
Willis, RJ
Wallace, RB
Mucha, LM
Straus, WL
Fendrick, AM
[J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2001, 16 (11) : 770 - 778
[4] Liu J., 2017, Assessing the Preparedness of the U.S. Health Care System Infrastructure for an Alzheimer's Treatment, DOI DOI 10.7249/RR2272
[5] Estimated Annual Spending on Aducanumab in the US Medicare Program
Mafi, John N.
Leng, Mei
Arbanas, Julia Cave
Tseng, Chi-Hong
Damberg, Cheryl L.
Sarkisian, Catherine
Landon, Bruce E.
[J]. JAMA HEALTH FORUM, 2022, 3 (01): : E214495
[6] Lecanemab in Early Alzheimer's Disease
van Dyck, Christopher H.
Swanson, Chad J.
Aisen, Paul
Bateman, Randall J.
Chen, Christopher
Gee, Michelle
Kanekiyo, Michio
Li, David
Reyderman, Larisa
Cohen, Sharon
Froelich, Lutz
Katayama, Sadao
Sabbagh, Marwan
Vellas, Bruno
Watson, David
Dhadda, Shobha
Irizarry, Michael
Kramer, Lynn D.
Iwatsubo, Takeshi
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (01) : 9 - 21

← 1 →